<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="159784">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01936194</url>
  </required_header>
  <id_info>
    <org_study_id>6018</org_study_id>
    <nct_id>NCT01936194</nct_id>
  </id_info>
  <brief_title>The Effects of Polyunsaturated Fatty Acids (PUFA) on Allergic/Atopic Dermatitis</brief_title>
  <official_title>The Effects of Polyunsaturated Fatty Acids on Allergic/Atopic Dermatitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mead Johnson Nutrition</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>International Peace Maternity and Child Health Hospital of China welfare Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institute for Nutritional Sciences, SIBS, Chinese Academy of Science</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mead Johnson Nutrition</source>
  <oversight_info>
    <authority>China: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This clinical trial will study the effects of PUFA supplementation during pregnancy and
      lactation period on fatty acid composition in human milk and plasma of the mothers and the
      clinical outcome of atopic dermatitis in infants at increased risk.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">May 2016</completion_date>
  <primary_completion_date type="Anticipated">November 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)</study_design>
  <primary_outcome>
    <measure>Lipid Analysis</measure>
    <time_frame>Baseline, Delivery, Within one week after delivery, 6 weeks postpartum, 4 months postpartum</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Metabolomics Study of PUFA</measure>
    <time_frame>Baseline, Delivery, Within one week after delivery, 6 weeks postpartum, 4 months postpartum, 12 months postpartum</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Skin Prick Test to Common Allergens</measure>
    <time_frame>4 months postpartum, 12 months postpartum</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical Assessment of IgE-mediated Allergic Eczema</measure>
    <time_frame>4 months postpartum, 12 months postpartum</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fatty Acid Desaturase (FADS) Genotypes</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>immunoglobulin E  immunoglobulin E  Immunoglobulin E (IgE) Antibodies</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Immunological Biomarkers</measure>
    <time_frame>4 months postpartum, 12 months postpartum</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medically-confirmed adverse events collected throughout the study period</measure>
    <time_frame>12 months postpartum</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Atopic Dermatitis</condition>
  <arm_group>
    <arm_group_label>Docosahexaenoic Acid (DHA)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>High Olive Oil</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Control</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DHA+EPA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>DHA+EPA</intervention_name>
    <arm_group_label>DHA+EPA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>High Olive Oil</intervention_name>
    <arm_group_label>High Olive Oil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>DHA</intervention_name>
    <arm_group_label>Docosahexaenoic Acid (DHA)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Woman is pregnant between 16 and 20 weeks

          -  Mother delivers after 36 weeks

          -  Mother is willing to breast-feed for four months

          -  Mother has potential to deliver a child with increased risk of atopic
             dermatitis

          -  Signed Informed Consent

        Exclusion Criteria:

          -  Mother is smoking

          -  Disease with influence on breast feeding

          -  Complicated pregnancy

          -  Allergic to seafood

          -  Allergic to soy

          -  Allergic to marine fish

          -  Mother has more than two salmon or tuna meals per week

          -  Mother is undergoing treatment with anticoagulants
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhiwei Liu, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>International Peace Maternity and Child Health Hospital of China Welfare Institution</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Huiyong Yin, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute for Nutritional Sciences, SIBS, Chinese Academy of Science</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bryan Liu, Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>Mead Johnson &amp; Company</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Huimin Liu</last_name>
    <phone>86-20-82156129</phone>
    <email>huimin.liu@mjn.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bryan Liu</last_name>
    <phone>812-459-2075</phone>
    <email>Bryan.liu@mjn.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>International Peace Maternity and Child Health Hospital of China welfare Institute</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200030</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zhiwei Liu, M.D.</last_name>
      <phone>86-21-64073899</phone>
      <email>liuzhiwei@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Zheng Tang, M.D.</last_name>
      <phone>86-21-64073899</phone>
      <email>tangzheng1971@aliyun.com</email>
    </contact_backup>
    <investigator>
      <last_name>Zhiwei Liu, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 2, 2013</lastchanged_date>
  <firstreceived_date>August 27, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dermatitis</mesh_term>
    <mesh_term>Dermatitis, Atopic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
